the journal of Pharmacy Technology Harvey AK Whitney Jr PUBLISHER AND EDITOR Volume Eleven January through December 1995 Published bimonthly by Harvey Whitney Books Company: ISSN 8755 1255; Coden JPTEEB; 6(1-6) 1-302(1995) APPRECIATION TO jPT REFEREES The individuals listed below reviewed manuscripts for /PT between October 2, 1994 and October 31, 1995. We are glad to take this opportunity to acknowledge our referees and to thank them for their time and effort. Michael R Alexander Janet L Fox Endalish Mulugeta Mary G Amato Frederick Gerald Freitag Mark A Munger Paul W Ament David J Frohnapple Kim M Murray Guy W Amsden Matthew A Fuller Michael B Nichol Leigh A Anderson William Greene Reid A Nishikawa Richard A Angorn Aileen M Grimm Thomas D Nolin William H Asbury James B Groce Donald S North Bruce G Augustin Ashok K Gumbhir Mark A North Janos Bacsanyi Daniel P Haas Linda L Norton Cindy M Bakst Ronald S Hadsall C Dwayne Ogzewalla Umesh V Banakar Kathleen Olsen Hagmeyer Mark P Okamoto John H Banker William R Outman Saleh A Bawazir Randy C Hatton Mary T Pasko Paul P Belliveau Dean G Haxby Kathleen Sue Pawlicki Robert W Bennett Richard A Helms Steven M Pepin Guru V Betageri Lisa Herman Kimberly L Perez Stephane Bissonnette John D Hirsh Stanley L Pestotnik Darrel C Bjornson Valerie W Hogue Cynthia M Phillips Diane Blais Carol Elaine Howard Julie Ann Porter Carole A Bradley Darrell T Hulisz Janice L Putnam Laurie L Briceland Michael Iskedjian Ralph H Raasch Karim Anton Calis Linda A Jaber Jack H Raber Betsy A Carlisle Eric A Jackson JohnJ Raia Bruce C Caristedt Brian E Jahns Dennis W Raisch Thomas Catalano Michael W Jann Robert P Rapp Thomas YK Chan Timothy S Jennings Cathlene E Richmond Fred N Choy Julie A Johnson Holly S Rickman Margaret M Chrymko Lori A Jones Wolfgang A Ritschel Christina L Cognata Kathleen A Kaa Michael T Rupp D Michael Collins Pramodini B Kale-Pradhan Gary Sachtler Timothy R Covington Cynthia A Kikugawa Rosalie Sagraves Vicki S Crane John L Kirkland Dawn Sande-Lykken Kelley A Cunny Donald T Kishi Russell E Seay Clarence E Curry James A Koestner Georganne Sebastian Erica A Danos Alice Kowalczyk Randall D Seifert Joseph M De Vito Donna M Kraus Marion K Slack Robert L Deamer David A Kuhl Gary H Smith Mariela Diaz-Linares Barbara A LaPierre Paul L Doering Iris A Latorre-Perez Cara Dong Marc Levine Jean B Douglas Ingrid K Lewis David F Driscoll Julio R Lopez Murray P Ducharme Rex S Lott Wendy Duncan-Hewitt Andrew Lowe Bruce Edgren Aileen Bown Luzier Blake Edwards Daniel S Maddix David ] Edwards Mina Makooi-Morehead Eli D Ehrenpreis Patricia A Marken Gaylene Byers Tsipis Thomas R Einarson Vincent F Mauro Imeine A Ukhun Allan J Elisworth Janet McCombs Bert L Vallee Steven R Erickson Lisa McDermott William E Wade Brian L Erstad Karen H McGee Mary L Wagner Susan C Fagan Kellie D McQueen Julianne K Whipple Kenneth H Falchuk Margaret A Medicus-Bringa Anthony P Young Evelyn Farinas Helen } Metz Heber W Youngken Karen B Farris Devona Mills Frank Zaran William E Fassett Dan Mitchell John A Zeisler Mireille Fermet Michael S Monaghan George G Zhanel Nancy F Fjortoft Amold S Monto Janice Fong Sunahara Nancy A Morgan Margaret L Fowler Gregory B Morrill Volume 11, Copyright 1995 by Harvey Whitney Books Company, PO Box 42696, Cincinnati, OH 45242, USA; 513/793-3555, FAX 513/793-3600. Permission to reproduce articles in whole or in part must be obtained from the publisher. Printed in the United States. Vowume 11 Novemser/Decemser 1995 INDEX, the journal of Pharmacy Technology Votume ELeveN—JANUARY THROUGH Decemser 1995 January/February Pages 1— 40 July/August Pages 145-192 March/April Pages 41-88 September/October Pages 193-248 May/June Pages 89-144 November/December Pages 249-302 Apparent Hemolysis in an AIDS Patient Re- Childhood Injuries and Pediatric Medical A-B ceiving Trimethoprim/ JQ 216. 4, azole: Emergencies (US), 191 Case Report and Literature Review (A), CibaGeneva Reports on Pharmacy Benefit 256 Trends (PF), 239 AAPT, see American Association of Pharma- Aprotinin, adverse effects (A), 161; pharma- Citrate: Valence and Milliequivalent Consid- cy Technicians cokinetics (A), 157 erations (A), 60 AIDS, see Acquired immunodeficiency syn- Aprotinin: No Justification for Current Use Citrome, Leslie (author), Use of Lithium, Car- drome (A), 156 bamazepine, and Valproic Acid in a State- APhA , see American Pharmaceutical Associ- Association of Pharmacy Technicians for the Operated Psychiatric Hospital (A), 55 ation United Kingdom (WN), 236; conference, 20 Clarithromycin Effective for Eradication of Abbott Files New Drug Application for In- Atypical Neuroleptic Malignant Syndrome H. pylori and Prevention of Ulcer Recur- halation Anesthetic (WN), 28 Presenting as Rhabdomyolysis, Altered rence (TT), 177 Abbott Introduces New Three-Line Infusion Consciousness, and Leukocytosis (A), 173 Claveria, Luis Erick (coauthor), see Duarte, System (WN), 285 Autoinjector Approved (WN), 286 Jacinto, 226 N-Acetylcysteine, epilepsy (TT), 23 Azaz-Livshits, Tanya L (author), Atypical Clinical Trial Results Announced for Peri- Acquired immunodeficiency syndrome, Neuroleptic Malignant Syndrome Present- odontal Drug (WN), 182 thalidomide (TT), 23; trimethoprim /sulfa- ing as Rhabdomyolysis, Altered Conscious- Clozapine, iatrogenic salivary gland swelling methoxazole, hemolysis (A), 256 ness, and Leukocytosis (A), 173 (A), 18 Adverse effects, aminophylline, myocardial Barre-NMC Introduces Miconazole Vaginal Common cold, zinc lozenges (A), 110 infarction (A), 53; aprotinin (A), 161; beta,- Suppositories (WN), 130 Comparison of Predicted and Measured En- agonists, myocardial infarction, 53; clozap- Beta,-agonists, myocardial infarction (A), 53 ergy Expenditure in Mechanically Venti- ine, salivary gland swelling (A), 18; enal- Birmingham, Mary C (coauthor), see Schen- lated Obese Patients (A), 47 april, angioedema, 200; ranitidine, thrombo- tag, Jerome J, 203 Compliance, improvement (A), 167 cytopenia (A), 263; trimethoprim /sulfa- Bismuth phosphate, sclerotherapy, hydro- Computers, bulletin-board services (A), 95 methoxazole, hemolysis (A), 256 celes (A), 10 Computers: Errors in—-Errors out (FL), 233 All Units Are Not Equal (FL), 26 Blood Supply Safety (FL), 232 Confusion Between Opioid Analgesics Re- Allen, Jill E (author), book review, 45 Books Received, 7, 93, 151, 254 sults in Deaths (FL), 178 American Association of Pharmacy Techni- Bristol-Myers Squibb Launches Kidney- Continuous Digital Temperature Meter In- cians, convention, 83; Designs Strategic Watch (WN), 29 troduced (WN), 287 Plan (PF), 133; regional meetings, 32 Brochure for Teens with Asthma (WN), 74 Controlled-Release "Booster" Could Maxi- American Pharmaceutical Association, Ap- Buspirone and Sertraline in the Treatment of mize Effectiveness of Future AIDS Vac- proves New Code of Ethics for Pharmacists a Patient with Refractory Obsessive-Com- cine (WN), 28 (PF), 79; code of ethics (E), 41 pulsive Disorder (A), 50 Cooper, Brad E (author), Aprotinin: No Justi- Aminophylline, myocardial infarction (A), 53 fication for Current Use (A), 156 Amphotericin B, liposomal, lipid formula- Coria, Francisco (coauthor), see Duarte, Jacin- tions (A), 99 to, 226 Ampicillin/sulbactam, resistance (A), 153 C-D Cost Implications of Using Inhaled Nitric Analgesia, epidural, sufentanil (A), 13 Oxide Compared with Epoprostenol for Announcements, American Association of Pulmonary Hypertension (A), 163 Pharmacy Technicians, convention, 83, re- Carbamazepine, prescribing, psychiatric hos- Cranberry Juice Concentrate Available in gional meetings, 32; Association of Pharma- pital (A), 55 New Capsule Form (WN), 77 cy Technicians, conference, 20; Pharmacy Carboplatin and Cisplatin (PF), 186 Cupo, Jennifer H (coauthor), see Rho, Jay P, Technician Educators Council, annual meet- Cardura Now Indicated for Benign Prostatic 99 ing, 81, 138, 241 Hyperplasia (WN), 127 DEA Removes Ephedrine Threshold (PF), 185 Antazoline, sclerotherapy, hydroceles (A), 10 Carr, James R (coauthor), see Schentag, Danos, Erica A (author), book review, 45 Antibiotics, cost savings, benchmarking tech- Jerome J, 203 Davé, Mahendra (author), Iatrogenic Salivary niques (A), 203 Changing Patterns of Resistance to Ampi- Gland Swelling (A), 18 Antiinflammatory drugs, nonsteroidal, diag- cillin/Sulbactam (A), 153 Development and Benefits of a Pharmacy nosis, neoplastic vs. infectious fever (A), 211 Cheng, Eugene Y (author), Epidural Sufen- Technician Career Ladder (FL), 278 Apomorphine, intranasal, Parkinson's disease tanil Infusion for Postoperative Analgesia Diaz-Linares, Mariela (author), book review, (A), 226 (A), 13 150 JOURNAL OF PHARMACY TECHNOLOGY Vowume 11 Novemser/Decemser 1995 297 Directory of Pharmacist-Operated — In- FDA he Label Chafnorg Taceri ne Guidelines for Medication Incentive Pro- formation Centers in the US (A), 270 (PF), 290HCFA Publishes OBRA ‘90 Divalproex Sodium Indicated for Manic FA Agpeoves Now lndlcation farW estadia Final Rule (PF), 132 Episodes Associated with Bipolar Disor- (TT), 230 HIV W; Syndrome (FL), 180 der (TT), 231 FDA Clears Alprostadil for Marketing (WN), Habib, Michael P (coauthor), see Feil, Rebec- Dosage form, epidural, sufentanil (A), 13; in- 238 ca A, 267 tranasal, apomorphine (A), 226; lozenges, FDA Grants Novopharm Conditional Hanson, Stephen C (coauthor), see Schentag, zine (A), 110; sublingual, nifedipine (A), 21 ANDA for Ranitidine (WN), 30 Jerome J, 203 sclerotherapy, hydroceles (A), 11 FDA Proposes Safety Measures to Prevent Hemochron Jr. Microcoagulation Analyzer Dronabinol Effective in AIDS-Induced Childhood Iron Poisoning (PF),3 3 for Bedside Hemostasis Managemen, t Anorexia (TT), 123 FDA Recommends Approval of Nonpre- (WN), 77 Drug Advisory Committees: Getting Out- scription Nizatidine (WN), 285 Herbal Remedies (A), 214 side Advice for Close Call(FsL) , 124 Feil, Revecca A (author), Effect of Low-Dose Hermann, Joachim J (author), Citrate: Valence Drug Misadventure Conference Results (PF), Fluconazole on Theophylline Serum Con- and Milliequivalent Considerations (A), 60 187 centrations in Healthy Volunteers (A), 267 Hess, Andrea D (author), book review, 45 Drug for Non-Small Cell Lung Cancer Ap- Felodipine Label to Reflect New Starting Hoffmann-La Roche Launches EC-Naprosyn proved for US Market (WN), 75 Dose (WN), 284 (WN), 129 Drug information, center directory (A), 270; First Meeting of ASHP Pharmacy Technician Hydroceles, sclerotherapy (A), 8 computerized bulletin-board services (A),9 5 Advisory Group (PF), 186 Hypertension, pulmonary, inhaled nitric ox- Duarte, Jacinto (author), Efficacy of Intranasal First National Pharmacy Technician Certifi- ide vs. epoprostenol, 163 Apomorphine in Parkinson's Disease (A), cation Examination Targeted for July 1995 Iatrogenic Salivary Gland Swelling (A), 18 226 Administration (PF), 78 Improving Medication Compliance: A Prac- Flonase Nasal Spray Now Available in the tical Intervention (A), 167 US (WN), 31 International Joint Venture to Develop Im- Fluconazole, no interaction, theophylline (A), proved Pharmaceuticals (WN), 74 E-F 267 Is Scientology Science Fiction? (E), 89 Foster, Mattie S, (author) Subscription Price journal of Technology, author Too High!? (L), 6 guidelines ifc-J/F, ife-M/A, ifc-M/J, ife-J/A, Earl-Salotti, Grace L (author), Ketoconazole Fraenkel, Yehuda M (coauthor), see Azaz- ifc-S/O, ife-N/D; reprints, columns, opin- in the Prevention of Acute Respiratory Dis- Livshits, Tanya L, 173 ions, & standards ibe-M/A, major articles tress Syndrome (A), 221 Frazier, Jerry L (coauthor), see Yim, Josephine ibe-J/F, ibe-M/J, ibe-S/O, opinions and Easy Breathing (FL), 126 M, 263 standards ibe-J/A, ibc-N/D; subscription Eby, George A (author), Linearity in Dose-Re- Free Sample of Low-Dose Aspirin (WN), order form, 40, 88, 146, 194, 301 sponse from Zinc Lozenges in Treatment of 284 Kavanagh, Ronald E (author), book review, 150 Common Colds (A), 110 From the Literature, All Units Are Not Equal, Ketoconazole in the Prevention of Acute Editorials, Ponte, Charles D, Women’s 26; Blood Supply Safety, 232; Computers: Respiratory Distress Syndrome (A), 221 Health—An Important Arena for Pharma- Errors in—Errors out, 233; Confusion Be- Ketoprofen Approved for Over-the-Counter ceutical Care Efforts, 193; Richardsen, Nan- tween Opioid Analgesics Results in Death, Use (WN), 286 cy Hopple, The Evolution of the Pharma- 178; Development and Benefitosf aP har- Kirschenbaum, Harold L (coauthor), see cists’ Code of Ethics, 41; Welty, Timothy E, macy Technician Career Ladder, 278; Drug Rosenberg, Jack M, 270 Doomsday or Opportunity? Pharmacy in Advisory Committees: Getting Outside Ad- Kit Combines Patient Aids, Cardizem CD the Midst of Change, 249, Pharmacy—A vice for Close Calls, 124; Easy Breathing, Samples (WN), 182 Clinical Profession?, 145; Whitney, Harvey 126; Electromagnetic Interference May Knapp, Judy Ann (author), book review, 254 AK Jr, Is Scientology Science Fiction?, 89, Cause Problems with Some Medical De- Kumar, Princy N (coauthor), see Yasuda, Sal- Ten Years of Important Progress for Techni- vices, 27; HIV Wasting Syndrome, 180; ly Usdin, 153 cians, 1 Pharmacy Technicians, Part 1: National Cer- LaCalamita, Stephanie Brill (author), Sclero- Effect of Low-Dose Fluconazole on Theoph- tification, 278; Psoriasis Treatments, 179; therapy of Hydroceles (A), 8 ylline Serum Concentrations in Healthy Simplifying Overcrowded Injection Labels, Lamictal Receives Clearance for Marketing Volunteers (A), 267 72; Views of Job Responsibilities for Phar- in US (WN), 76 Effective Medical Therapy for Symptomatic macy Technicians, 280; Zero—Much Ado Lee, Mary (coauthor), see LaCalamita, BPH (TT), 229 About Nothing, 178 Stephanie Brill, 8 Efficacy and Toxicity of Amphotericin B Li- Fuentes, Robert J( coauthor), see Rosenberg, Letter, Subscription Price Too High!?, 6 Efficacy of Ianntdr anLaispaild AFoprommuolraptihoinnse (iA)n, 99 Jack M, 270 Levin, Gary M (coauthor), see Veivia, Amy J, 50 Parkinson's Disease (A), 226 Linearity in Dose—Response from Zinc El-Jandali, Amer (coauthor), see Raggi, Pao- Lozenges in Treatment of Common Colds Elelco,t r5o3 magnetic Interference May Cause G-L (A), 110 Lithium, prescribing, psychiatric hospital (A), Problems with Some Medical Devices 55 (FL), 27 Garcia, Francisco M (coauthor), see Duarte, Enalapril-Induced, Near-Fatal Angioedema Jacinto, 226 (A), 200 Generic Hetastarch Product Available (WN), Epidural Sufentanil Infusion for Postopera- 183 tive Analgesia (A), 13 Genetronics Develops New Drug Delivery M-N Epoprostenol, pulmonary hypertension (A), Technology (TT), 176 163 Gentamicin, dosing, neonates (A), 105 Machuga, David T (coauthor), see Rao, Satya, Ergotrate Maleate Again Available (WN), 128 Girls Close the Calcium Gap with Dairy 200 Erstad, Brian L (coauthor), see O'Connell, Foods (TT), 229 Maldonado, Ivan L (coauthor), see Earl-Salot- Helen M, 47 Gora-Harper, Mary Lea (author), Value of ti, Grace L, 221 Ethanolamine oleate 5%, sclerotherapy, Pharmacy-Related Bulletin Board Services Market for AIDS Therapeutics to Reach $1.8 hydroceles (A), 9 as a Drug Information Resource (A), 95 Billion in 1998 (TT), 71 Ethics, code, development (E), 41, (PF) 79 Graves, Allen H (coauthor), see Reinke, C Marketing Approval for Norditropin Hu- Expanded Services Include Continuing Edu- Michael, 256 man Growth Hormone (WN), 183 cation Programs (WN), 236 Gray, Thomas M (author), Reevaluation of Martin, Bradley C (coauthor), see Perri, FDA Approves Heart-Assist Device (WN), 31 Gentamicin Dosing in the Neonatal Popula- Matthew, 167 FDA Approves Hepatitis A Vaccine (WN), tion (A), 105 Mataix, Angel L (coauthor), see Duarte, Jac- 128 Groft, Stephen C (author), book review, 253 into, 226 298 JOURNAL OF PHARMACY TECHNOLOGY Vowume 11 Novemser/Decemser 1995 McCombs, Janet (author), book review, 46 Nitric oxide, pulmonary hypertension (A), Urged with Potassium Chloride Concen- McGuire, Howard (coauthor), see Rosenberg, 163 trate Injection, 185; Prescription Drug Mis- Jack M, 270 Nonprescription Ibuprofen Suspension use Costs Economy Billions, 290; Prescrip- MedSaver Syringe Introduced (WN), 183 Available for Children (WN), 286 tion Drug Price Increases Continue Medical Therapy Effective for Treatment of Nunn, AnthonyJ (coauthor), see Petros, Moderate Pace, 239 Benign Prostatic Hyperplasia (TT), 123 Andy J, 163 Pharmacy Technician Educators Council, Medication Errors (PF), 185 1995 committees appointed, 81; annual Microcarb Announces Testing of Campy- meeting, 81, 138 lobacter Vaccine with US Navy (TT), 275 Technicians Complete Certifica- Misadministration of Oral Medications O-P tion Transfer Process (PF), 289 Through Central Intravenous Lines (PF), Technicians, Part 1: National Cer- 186 tification (FL), 278 Morrill, Gregory B (coauthor), see Feil, Re- Obesity, mechanical ventilation (A), 47 Pharmacy practice, clinical (E), 145; future becca A, 267 Ob ve-c ve disorder, buspirone, roles (E) 249; women's health (GE), 193 Murchison, Daniel J (coauthor), see Naut, sertraline (A),5 0 Pharmacy—A Clinical Profession? (E), 145 Philip E, 93 O'Connell, Helen M (author), Comparison of PHARMTRAX Software Available (WN), Murray, Kim M (coauthor), see Rabon, Par- Predicted and Measured Energy Expendi- 76 rish G, 211 ture in Mechanically Ventilated Obese Pa- Phenol, sclerotherapy, hydroceles (A), 10 Myocardial Infarction and Dynamic Left tients (A), 47 Picower Institute Announces New Ventricular Outflow Obstruction Induced Ogzewalla, C Dwayne (author), book review, HIV/AIDS Treatment (WN), 75 by Bronchodilator Therapy (A), 53 197, 198 Pierce, Phillip F (coauthor), see Yasuda, Sally NABP to Revamp Transfer of Licensure Pro- Once-Daily Dosing Effective for Bacterial Usdin, 153 gram (PF), 131 Vaginosis Therapy (TT), 277 Polidocanol, sclerotherapy, hydroceles (A), 10 NCPIE, AARP, and Merck Promote "Brown Oral Sustained-Release Formulations Are Polk, Marsha A (author), The Pharmacy Tech- Bag" Medicine Review (WN), 74 Not Created Equal (US), 38 nologist: Versatile Element in the Provision Naltrexone Receives FDA Clearance for the PTCB Announces July 1995 Certification Ex- of Healthcare Services (A), 67 Treatment of Alcohol Dependence (TT), 70 amination Results (PF), 289 Ponte, Charles D (author), Women's Health— National Technician Examination Dates An- PTEC News, 1995 Committees Appointed, 81; An Important Arena for Pharmaceutical nounced (PF), 131 1995 PTEC Annual Meeting—Philadelphia, Care Efforts (GE), 193; book review, 197 Naut, Philip E (author), book review, 93 July 8-2, 241; annual meeting, 138 Powell, Hannah S (coauthor), see Veivia, Neuroleptic malignant syndrome, atypical Paladino, Joseph A (coauthor), see Schentag, Amy J, 50 (A), 173 Jerome J, 203 Precautions Urged with Potassium Chloride Neuroprotective Agent Shows Promise in Parkinson's disease, intranasal apomorphine Concentrate Injection (PF), 185 Treating Stroke (TT), 229 (A), 226 Prefilled Disposable Smartdose Infusion New Antibiotics Active Against Drug-Resis- Patients with Disabling Neurologic Disor- Pump (WN), 284 tant Disease Strains (TT), 276 ders Respond to Novel Drug Therapy Prescribing, nifedipine, sublingual (A), 21 New Cervical Ripener Cleared for Market- (TT), 23 Prescription Drug Misuse Costs Economy ing (WN), 237 Pediatrics, gentamicin dosing, neonates (A), Billions (PF), 290 New Dosage Form of Metronidazole (WN), 105 Prescription Drug Price Increases Continue 286 Perri, Matthew (author), Improving Medica- Moderate Pace (PF), 239 New Drugs for Iron Overload Diseases En- tion Compliance: A Practical Intervention Pricing Data Introduced for Canadian Drug ter Animal Testing (TT), 176 (A), 167 Products (WN), 236 New Easy-to-Read Brochure Series on Over- Petros, Andy J (author), Cost Implications of Prilosec Now Available to Treat Erosive the-Counter Drugs (WN), 75 Using Inhaled Nitric Oxide Compared with Esophagitis (TT), 275 New HIV Test Licensed (WN), 183 Epoprostenol for Pulmonary Hypertension Pritchard, Franklin L (coauthor), see Perri, New Orajel CoverMed (WN), 237 (A), 163 Matthew, 167 New Product Reattaches Retinas (WN), 130 PharmaCE, order form, 34, 85, 141, 188, 242, Psoriasis Treatments (FL), 179 New Publications, AIDS: Images of the Epi- 295; test questions, 35, 84, 140, 189, 243, 293 demic, 150; Certification Review for Phar- Pharmacists Polled on Role of Technicians, macy Technicians, 93; Drug Information Certification (PF), 131 Handbook, 1994-1995. 2nd Edition, 45; Pharmacokinetics, aprotinin (A), 157 Q-R Drug-Induced Liver Disease, 199; Hand- Focus, AAPT Designs Strategic book of Pharmaceutical Excipients. 2nd Plan, 133; APhA Approves New Code of Edition, 253; Herbal Drugs and Phytophar- Ethics for Pharmacists, 79; Carboplatin and Quotes, historical, Cost and Contamination maceuticals, 198; Herbs of Choice: The Cisplatin, 186; CibaGeneva Reports on Study with Technicians, Miller WA, Smith Therapeutic Use of Phytomedicinals, 197; Pharmacy Benefit Trends, 239; DEA Re- GL, Latiolais CJ, Drug Intelligence and Clini- Medication Teaching Aids, 45; Principles of moves Ephedrine Threshold, 185; Drug cal Pharmacy (1971), 59; Manpower Forecast, Drug Information and Scientific Literature Misadventure Conference Results, 187; Rodowskas CA Jr, Dickson WM, American Evaluation, 46; Searching for Magic Bullets, FDA Proposes Safety Measures to Prevent Journal of Hospital Pharmacy (1973), 24; Phar- 253; Sterile Dosage Forms—Their Prepara- Childhood Iron Poisoning, 33; First Meeting macy Directors’ Attitudes, Walizer DG, tion and Clinical Application. 4th Edition, of ASHP Technician Advisory American Journal of Hospital Pharmacy (1974), 150; The Health of Young People: A Chal- Group, 186; First National Pharmacy Tech- 283; Policy Decisions by Technicians?, Bark- lenge and a Promise, 254; The Treatment of nician Certification Examination Targeted er KN, Smith MC, American Journal of Hospi- Epilepsy—Principles and Practice, 6; Un- for July 1995 Administration, 78; Guidelines tal Pharmacy (1972), 294; Sterile Compound- derstanding the Pill: A Consumer's Guide for Medication Incentive Programs2,9 0 ing by Technicians, Zilz DA, Drug Intell- to Oral Casbenytien, 197; Women—A HCFA Publishes OBRA '90 Final Rule, 132; igence and Clinical Pharmacy (1971), 66; Tech- Force in World Medication Errors, 185; Misadministration nician Training Program, Pike M, American Congress 1991: InternationalF orum for of Oral Medications Through Central Intra- Journal of Hospital Pharmacy (1966), 269; The Women in venous Lines, 186; NABP to Revamp Trans- Role of Pharmacy Support Staff in Hospi- New Review Text for Seases Technician fer of Licensure Program, 131; National tals, Australian Journal of Hospital Pharmacists Certification Examination Available (WN), Technician Examination Dates Announced, (1986), 104; Training for Rural Healthcare, 28 131; New Rules for Children's Medicines, Knight JL et al., American Journal of Hospital New Rules for Children's Medicines (PF), 132 132; PTCB Announces July 1995 Certifica- Pharmacy (1974), 175 New Therapy for Shingles Released for tion Examination Results, 289; Pharmacists Rabon, Parrish G (author), Role of Nonster- Marketing (WN), 285 Polled on Role of Technicians, Certification, oidal Antiinflammatory Drugs in the Differ- Nifedipine, sublingual, inappropriate pre- 131; Pharmacy Technicians Complete Certi- ential Diagnosis of Neoplastic Fevers Ver- scribing (A), 21 fication Transfer Process, 289; Precautions sus Fevers of Infectious Etiology (A), 211 JOURNAL OF PHARMACY TECHNOLOGY Vowume 11 Novemser/Decemser 1995 299 Raggi, Paolo (author), Myocardial Infarction Sloan-Kettering and SoloPak Sign Agree- Trimethoprim/sulfamethoxazole, hemolysis and Dynamic Left Ventricular Outflow Ob- ment (WN),3 0 (A), 256 struction Induced by Bronchodilator Thera- Sodium sulfate, sclerotherapy, hy- Turner, Helen C (coauthor), see Yasuda, Sally ch (An),e 53 droceles (A), 10 Usdin, 153 Ranitidine, thrombocytopenia (A), 263 Starr, Cynthia H (coauthor), see Rosenberg, Turner, Sean C (coauthor), see Petros, Andy J, Ranitidine and Thrombocytopenia (A), 263 Jack M, 270 163 Rao, Satya (author), Enalapril-Induced, Near- Stevens, Rom A, (coautsheeo Crhe)ng , Eu- Tyler, Varro E (author), Herbal Remedies (A), Fatal Angioedema (A), 200 gene Y, 13 214 Ratzell, Michelle D (coauthor), see Earl-Sa- Stimate Nasal Spray Now Availatbo lTreea t lotti, Grace L, 221 Bleeding Disorders (WN), 30 Ravis, William R (author), book review, 253 Stommel, Kimberly A, (coauthor) see Cheng, ReadyPrice 20 Makes Debut (WN), 287 Eugene Y, 13 U-V Prescribing of Sub- Studies on New Asthma Compound Pre- lingual Nifedipine (A), 21 sented (WN), 127 Reed, Michael D, (author) book review, 6 Sufentanil, epidural, postoperative analgesia Unimed Pharmaceuticals Starts Crypto- Reevaluation of Gentamicin Dosing in the (A), 13 sporidium Clinical Trial (TT), 276 Neonatal (A), 105 Symmer, Lev I (coauthor), see Azaz-Livshits, University of lowa and Lederle Launch Na- Reinke, C Michael (author), Apparent Tanya L, 173 tionwide Surveillance Network to Track Hemolysis in an AIDS Patient Receiving Tagamet Receives Over-the-Counter Clear- Antibiotic-Resistant Bacteria (WN), 29 Trimethoprim /Sulfamethoxazole: Ca, se ance (WN), 237 Updating Your Skills, Childhood Injuries and and Literature Review (A), 256 Taylor, Jerry W — book review, 199 Pediatric Medical Emergencies, 191; Oral ReoPro Now Available in US (WN), 128 Technicians, occupational opportunities (A), Sustained-Release Formulations Are Not Research Group Validates Treatment of Bed- 67; progress documented (E), 1 Created Equal, 38; Safety of Drug Use in Wetting (TT), 275 Ten Years of Important Progress for Techni- Pregnancy: How Much of a ConceIrsn It ?, Resistance, ampicillin/sulbactam (A), 153 cians (E), 1 86; What About Medical Charts?, 142 distress syndrome, acute, keto- Test Your Knowledge, answers, 37, 82, 139, 190, 248, 296; questions, 4, 44, 92, 148, 196, conazole (A), 221 Rho, Jay P (author), Efficacy and Toxicity of 252 Techniques to Justify Amphotericin B Liposomal and Lipid For- Tetracycline, sclerotherapy, hydroceles (A), 8 the Evolution of Antibiotic Management Thalidomide Enters Phase II Study for Ma- Programs in Healthcare Systems (A), 203 mulations (A), 99 jor AIDS Condition (TT), 23 Use of Lithium, Carbamazepine, and Val- Richardson, Nancy Hopple (author), The Evolution of the Pharmacists’ Code of The Evolution of the Pharmacists' Code of proic Acid in a State-Operated Psychiatric Ethics (E), 41 Ethics (E), 41 Hospital (A), 55 The Pharmacy Technologist: Versatile Ele- Valproic acid, prescribing, psychiatric hospital Rindone, Joseph P (coauthor), see Feil, Re- becca A, 267 ment in the Provision of Healthcare Ser- (A), 55 vices (A), 67 Value of Pharmacy-Related Bulletin Board —s Evens (coauthor), see Raggi, Paolo, Theophylline, no interaction, fluconazole, 267 Services as a Drug Information Resource Therapeutic Trends, Clarithromycin Effective (A), 95 — David L, (coauthor) see Cheng, Eu- for Eradication of H. pylori and Prevention Vasavada, Balendu C (coauthor), see Raggi, gene Y, 13 Role of Nonsteroidal Antiinflammatory of Ulcer Recurrence, 177; Divalproex Sodi- Paolo, 53 Drugs in the Differential Diagnosis of um Indicated for Manic Associat- Veivia, Amy J (author), Buspirone and Sertra- ed with Bipolar Disorder, 231; Dronabinol line in the Treatment of a Patient with Re- Neoplastic Fevers Versus Fevers of Infec- Effective in AIDS-Induced Anorexia, 123; fractory Obsessive-Compulsive Disorder tious Etiology (A), 211 Effective Medical Therapy for Symptomatic (A), 50 Romazicon Labeling Revised (TT), 71 BPH, 229; FDA Approves New Indication Ventilation, mechanical, energy expenditure Rosenberg, Jack M (author), Directory of for Warfarin, 230; Genetronics Dev obesity (A), 47 Pharmacist ited Drug Information New Drug Delivery Technology, 176; Girls Views of Job Responsibilities for Pharmacy Centers in the US (A), 270 Close the Calcium Gap with Dairy Foods, Technicians (FL), 280 Ruiz, Maria Dolores (coauthor), see Duarte, 229; Market for AIDS Therapeuttoi Rcesac h Jacinto, 226 $1.8 Billion in 1998, 71; Medical Therapy Ef- fective for Treatment of Benign Prostatic Hyperplasia, 123; Microcarb Announces W-Z Testing of Campylobacter Vaccine with US S-T Navy, 275; Naltrexone Receives FDA Clear- ance for the Treatment of Alcohol Depen- Welty, Timothy E (author), Doomsday or Op- dence, 70; Neuroprotective Agent Shows portunity? Pharmacy in the Midst of Sacchi, Terrence J (coauthor), see Raggi, Pao- Promise in Treating Stroke, 229; New Anti- Change (E), 249; Pharmacy—A Clinical Pro- lo, 53 bitiotics Active Against Drug-Resistant Dis- fession? (E), 145; (author) Safety of Drug Use in Pregnancy: How ease Strains, 276; New Drfuor Igrons Ove r- What About Medical Charts? (US), 142 Much of a Concern Is It? (US), 86 load Diseases Enter Animal Testing, 176; What's New, Abbott Files New Drug Applica- San Jose, Maria Angeles (coauthor), see Once-Daily Dosing Effective for Bacterial tion for Inhalation Anesthetic, 28; Abbott Duarte, Jacinto, 226 Vaginosis ae277; Patients with Dis- Introduces New Three-Line Infusion Sys- Schentag, Jerome J (author), Use of Bench- abling Neurologic Disorders Respond to tem, 285; Association of Pharmacy Techni- marking Techniques to Justify the Evolution Novel Drug Therapy, 23; Prilosec Now cians for the United Kingdom, 236; Autoin- of Antibiotic Management Programs in Available to Treat Erosive Esophagitis, 275; jector Approved, 286; Barre- NMC Healthcare Systems (A), 203 Research Group Validates Treatment of Introduces Miconazole Vaginal Supposito- Sclerotherapy of Hydroceles (A), 8 Bed-Wetting, 275; Romazicon Labeling Re- ries, 130; Bristol-Myers Squibb Launches Sempere, Angel P (coauthor), see Duarte, Jac- vised, 71; Thalidomide Enters Phase II KidneyWatch, 29; Brochure for Teens with into, 226 Study for Major AIDS Condition, 23; Uni- Asthma, 74; Cardura Now Indicated for Be- Sertraline, with buspirone, obsessive-compul- med Pharmaceuticals Starts Cryptosporidium nign Prostatic Hyperplasia, 127; Clinical Tri- sive disorder (A), 50 Clinical Trial, 276 al Results Announced for Periodontal Simplifying Overcrowded Injection Labels Thomas, Jennifer K (coauthor), see Reinke, C Drug, 182; Continuous Digital Temperature (FL), 72 Michael, 256 Meter Introduced, 287; Controlled-Release Single-Dose Vial of TheraCys Introduced Timpone, Joseph G (coauthor), see Yasuda, “Booster” Could Maximize Effectiveness of (WN), 238 Usdin, 153 Future AIDS Vaccine, 28; Cranberry Juice Skin Care Documentary Now Available trans Fats Do Not Increase Heart Attack Risk Concentrate Available in New Capsule (WN), 238 (WN), 127 Form, 77; Drug for Non-Small Cell Lung 300 JOURNAL OF PHARMACY TECHNOLOGY Vowume 11 Novemser/Decemser 1995 Cancer Approved for US Market, 75; Ergo- Sloan-Kettering and SoloPak Sign Agree- trate Maleate Again Available, 128; Expand- ment, 30; Stimate Nasal Spray Now Avail- INDEX ABBREVIATIONS ed Services Include Continuing Education able to Treat Bleeding Disorders, 30; Studies Programs, 236; FDA Approves Heart-Assist on New Asthma Compound Presented, A: Article Device, 31; FDA Approves Hepatitis A Vac- 127; Tagamet Receives Over-the-Counter E: Editorial cine, 128; FDA Approves Label Change for Clearance, 237; trans Fats Do Not Increase FL: From the Literature Tacrine, 236; FDA Clears Alprostadil for Heart Attack Risk, 127; University of lowa GE: Guest Editorial Marketing, 238; FDA Grants Novopharm and Lederle Launch Nationwide Surveil- ibe: Inside back cover Conditional ANDA for Ranitidine, 30; FDA lance Network to Track Antibiotic-Resistant ifc: Inside front cover Recommends Approval of Nonprescription Bacteria, 29; Upjohn Launches Disease L: Letters Nizatidine, 285; Felodipine Label to Reflect Company, 182 PF: Pharmacy Focus New Starting Dose, 284; Flonase Nasal Whitney, Harvey AK Jr, (author), Is Scientolo- PTEC: PTEC News Spray Now Available in the US, 31; Free gy Science Fiction? (E), 89; Ten Years of Im- TT: Therapeutic Trends Sample of Low-Dose Aspirin, 284; Generic portant Progress for Technicians (E), 1 US: Updating Your Skills Hetastarch Product Available, 183; Women's Health—An Important Arena for WN: What's New Hemochron Jr. Microcoagulation Analyzer Pharmaceutical Care Efforts (E), 193 for Bedside Hemostasis Management, 77; Woosley, Raymond L (coauthor), see Yasuda, Hoffmann-La Roche Launches EC-Napro- Sally U, 21 syn, 129; International Joint Venture to De- Yasuda, Sally U (author), Changing Patterns velop Improved Pharmaceuticals, 74; Keto- of Resistance to Ampicillin/Sulbactam (A), Statement of , Management, and monthly cir- profen Approved for Over-the-Counter 153 culation (6 issues, $68.00 annualloyf) th ej ournal of Phar- Use, 286; Kit Combines Patient Aids, Car- Yasuda, Sally U. (author), Reducing Inappro- macy Technology, publication no. 8755-1255. Owner, Har- dizem CD Samples, 182; Lamictal Receives priate Prescribing of Sublingual Nifedipine vey WhiBtoonks eComypan y. Publisher, editor, and Clearance for Marketing in US, 76; Market- (A), 21 moaf npaugbliinsgh ere,d iotwonre:r H, aand rpubvAlKic eWahtiiyotnn:e y8 0J4r4. HMeoandqtugaormteerrys ing Approval for Norditropin Human Yim, Josephine M (author), Ranitidine and Road, PO Box 42696, Cincinnati, OH 45242. Known Growth Hormone, 183; MedSaver Syringe Thrombocytopenia (A), 263 bondmohrtgaogees,l andd oteher rsecursity ,hold ers: Introduced, 183; NCPIE, AARP, and Merck Young, Mary A (coauthor), see Yasuda, Sally none. Average no. of copies of each issue from Septem- Promote "Brown Bag” Medicine Review, 74; Usdin, 153 ber 94 to September 95 and no. of copies of Septem- New Cervical Ripener Cleared for Market- Zero—Much Ado About Nothing (FL), 178 ber /October 95 issue: A. total no. copies printed (net press run) 1433, 1400; B. paid and/or requesctirecudla - ing, 237; New Dosage Form of Metronida- Zimmer, Gabrial (coauthor), see Schentag, tion (1) sales through dealers and carriers, street vendors, zole, 286; New Easy-to-Read Brochure Se- Jerome J, 203 and counters sales 0, 0; (2) paid or requested mail sub- ries on Over-the-Counter Drugs, 75; New Zinc, common colds (A), 110 scriptions 850, 915;C . total paid and/or requested circu- HIV Test Licensed, 183; New Orajel Cov- lation 850, 915; D. free distributionb y mail 110, 97; E. free erMed, 237; New Product Reattaches Reti- distribution outside the mail 0, 0; F.t otal free distribution 110, 97; G. total distribution 960, 1012; H. copinoet sdi s- nas, 130; New Review Text for Pharmacy tributed (1) office use, leftovers, spoiled 473, 388; I. total Technician Certification Examination Avail- 1433, 1400. No. of issues published annually: 6. Date of able, 28; New Therapy for Shingles Re- filing 27S eptember 1995. Signed: Harvey AK Whitney Jr, leased for Marketing, 285; Nonprescription Advertisers Publisher. Ibuprofen Suspension Available for Chil- dren, 286; PHARMTRAX Software Avail- Harvey Whitney Books, books, journals, soft- able, 76; Picower Institute Announces New ware, and reprints for pharmacy and phar- HIV/AIDS Treatment, 75; Prefilled Dispos- macotherapy, 134, 244; Certification Review able Smartdose Infusion Pump, 284; Pricing for Pharmacy Technicians, 37, 147, 235; Data Introduced for Canadian Drug Prod- Children's Medications: A Parent's Guide, ucts, 236; ReadyPrice 2.0 Makes Debut, 287; 255; combination subscriptions, 152; Phar- ReoPro Now Available in US, 128; Single- macy Technician Education & Training: Dose Vial of TheraCys Introduced, 238; Skin 1995 Directory, 184, 240, 288; Therapeutics Care Documentary Now Available, 238; in the Elderly, 36, 302 JOURNAL OF PHARMACY TECHNOLOGY Vowume 11 Novemser/Decemser 1995 301